FATE – fate therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus [Yahoo! Finance]
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell Product Candidate for Systemic Lupus Erythematosus
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics makes Bob Valamehr president and CEO [Yahoo! Finance]
Form 4 FATE THERAPEUTICS INC For: Dec 20 Filed by: Redmile Group, LLC
Form SCHEDULE 13D/A FATE THERAPEUTICS INC Filed by: Redmile Group, LLC
Form 144 FATE THERAPEUTICS INC Filed by: Redmile Group, LLC
Form 4 FATE THERAPEUTICS INC For: Dec 12 Filed by: Redmile Group, LLC
Form 8-K FATE THERAPEUTICS INC For: Nov 27
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.